Regulatory News
Thursday, December 8, 2016
BRIEF-Emergent BioSolutions says signs follow-on contract with CDC valued at up to $911 mln
* Emergent biosolutions - signs follow-on contract with cdc
valued at up to $911 million to supply to sns about 29.4 million
doses of biothrax through sept 2021
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment